EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA
The HIPRA bivalent recombinant protein Covid-19 vaccine is presently under the EMA’s rolling review.
India News
Latest in
India News
Sosei Heptares and AbbVie to develop therapies for neurological ailments
Sosei Heptares is entitled to receive up to $1.2bn in option, development and commercial milestone payments.
US FDA grants approval for Janssen’s Stelara to treat psoriatic arthritis
A completely human monoclonal antibody, Stelara hinders cytokines IL-12 and IL-23.
Samsung Biologics and GreenLight conclude Covid-19 vaccine engineering run
The clinical trial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.
AbbVie reports 4.5% rise in Q2 2022 net revenues
The company has provided an adjusted diluted EPS guidance range of $13.78 to $13.98 for the full-year 2022.
GreenLight and US NIH partner to develop Covid-19 vaccine for variants
The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.
Moderna signs contract to supply Covid-19 booster vaccines to the US
The initial 66 million vaccine doses are anticipated to be supplied this year.
Pfizer reports 53% operational growth in Q2 2022 revenues
In Q2 2022, the reported diluted EPS stood at $1.73 as against $0.98 in the year-ago quarter, indicating a 77%…